KIMS Q2 net profit rises 12% to ₹75 crore, revenue jumps 40% but margin declines

What happened

Krishna Institute of Medical Sciences (KIMS) reported second-quarter net profit of ₹75 crore, up 11.9% year on year, while revenue rose 39.9% to ₹1,344 crore. EBITDA, a measure of operating earnings before interest, taxes and other items, increased 27.5% to ₹260 crore, but its margin fell to 19.4% from 21.2%.

Confirmed

Global impact / market context

Revenue grew faster than profit, while the EBITDA margin fell, meaning KIMS kept less operating earnings from each rupee of revenue. If this pattern persists, rising activity may not translate into equally strong profit growth. The board’s hospital merger and operating agreement could also change how operations are organised.

Analyst inference

The figures show strong year-on-year growth in sales and operating earnings, but also pressure on the share of revenue retained as EBITDA. The article reports the stock closed at ₹745.35 on November 4 and had gained 20.98% year to date; it gives no market reaction to the results.

Confirmed

What to watch

1. Check whether future quarterly reports show the EBITDA margin stabilising or falling further, since that indicates whether higher revenue is converting into operating earnings. Analyst inference
2. Track the implementation and stated terms of the approved merger between KIMS Hospitals Private Limited and Krishna Institute of Medical Sciences Limited. Proposed
3. Look for details on the Westfort Hospital operating agreement, including its start and operating arrangements, to understand how it may affect KIMS Swastha’s activities. Analyst inference

Evidence

• Original source link unavailable